Using Human Growth Hormone For Anti-Aging And Rejuvenation
Since the first studies were performed on the human growth hormone and the FDA injectable prescription human growth hormone supplement was made available for limited use in 1985, there has been an intense interest in this modern medical miracle. Although the FDA has not approved HGH for use in cases outside the limited scope already mentioned, there nevertheless continues to be a demand for the product, particularly within demographic groups.
The trend toward using human growth hormone for the purpose of anti-aging and rejuvenation first began when the preliminary results of a clinical trial project were published in the New England Journal of Medicine in 1990. 8 The study was based on the supposition that the decline of human growth hormone in humans with the advance of age is responsible, at least in part, to decreased lean body mass, decreased bone mass, reduced exercise capacity (which contributes to a number of other serious health issues) and thinning of the skin as well as an increase in cardiovascular risk factors. Researchers theorized that replacing human growth hormone could possibly counteract the normal processes of aging that were related to the gradual decrease of human growth hormone over the years.
The subject of the study in question observed the effect of human growth hormone on twelve men between the ages of 61 and 81. After approximately six months of receiving the treatment, the lead researcher reported that the individuals who took HGH were shown to lose an average of 14% body fat and were actually able to gain almost 9% in lean body mass. Furthermore, the subjects were shown to have increased bone density and the elasticity of their skin was also increased.
It should be noted that each of the 12 participants were health, other than having a level IGF-1. At the conclusion of the study, Dr. Rudman stated, “The effects of six months of human growth hormone on lean body mass and adipose-tissue mass were equivalent in magnitude to the changes incurred during 10 to 20 years of aging.” 8
This statement, and the published results of the study, seemed to galvanize the medical community as well as many people seeking a proverbial fountain of youth, if not the FDA. Since Dr. Rudman’s study was published in 1990, there have been a number of other studies conducted.
A study was conducted at the Chelsea and Westminister Hospital in London by Dr.G. Moyle involving 12 HIV positive patients. The twelve patients were each given a daily dose of 4mg of recombinant human growth hormone over a twelve week period. During the following twelve weeks the same patients were given a dose of either human growth hormone or a placebo pill, on alternate days. This dosage was given only twice a week. At the end of the study during the first twelve weeks, the results published indicated that the abdominal fat levels had significantly decreased. Interestingly, leg and arm fat levels remained the same. All patients were reported to have experienced improvements in facial and leg appearances. During the second stage of the study, trial results indicated that the benefits which were apparent during the first phase of the study quickly began to diminish. In patients who were given the placebo, there was a return of abdominal fat. The final results of the study seem to indicate that human growth hormone assists in stabilizing limb fat loss.